Early Blood Test Predicts Survival in Patients with Metastatic Prostate Cancer
A study shows that measuring CTCs at the time of metastatic prostate cancer diagnosis can predict survival and guide treatment decisions.
Read MorePosted by Andy Lundin | Oct 7, 2024 | Prostate |
A study shows that measuring CTCs at the time of metastatic prostate cancer diagnosis can predict survival and guide treatment decisions.
Read MorePosted by Chris Wolski | Sep 10, 2024 | Prostate |
A new prostate cancer screening method could help better predict which patients need to undergo a biopsy, reducing unnecessary procedures.
Read MorePosted by Andy Lundin | Aug 30, 2024 | Prostate |
GRAIL’s Galleri multi-cancer early detection test demonstrates strong performance in preferentially identifying aggressive prostate cancers.
Read MorePosted by Chris Wolski | Aug 6, 2024 | Prostate |
A retrospective study shows that combining risk markers, MRI evaluation, and AI can more accurately predict prostate cancer risk.
Read MorePosted by Andy Lundin | Jul 23, 2024 | Prostate |
A prostate cancer test using protein and genetic markers improves diagnosis accuracy and reduces unnecessary procedures across ethnic groups.
Read More